MGX
Metagenomi Inc.

785
Mkt Cap
$95.33M
Volume
258,953.00
52W High
$4.92
52W Low
$1.23
PE Ratio
-1.08
MGX Fundamentals
Price
$2.54
Prev Close
$2.44
Open
$2.44
50D MA
$2.37
Beta
0.92
Avg. Volume
506,990.10
EPS (Annual)
-$2.09
P/B
0.49
Rev/Employee
$258,886.14
Loading...
Loading...
News
all
press releases
Here's Why Metagenomi (MGX) is a Great Momentum Stock to Buy
Does Metagenomi (MGX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·12d ago
News Placeholder
More News
News Placeholder
Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates
Metagenomi (MGX) delivered earnings and revenue surprises of +20.59% and +20.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Theravance Biopharma (TBPH) Reports Q2 Loss, Tops Revenue Estimates
Theravance Bio (TBPH) delivered earnings and revenue surprises of +42.86% and +53.76%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Xeris Biopharma (XERS) Reports Q2 Loss, Tops Revenue Estimates
Xeris Biopharma (XERS) delivered earnings and revenue surprises of +66.67% and +10.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
BeOne Medicines Ltd. - Sponsored ADR (ONC) Surges 4.0%: Is This an Indication of Further Gains?
BeOne Medicines Ltd. - Sponsored ADR (ONC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·4mo ago
News Placeholder
Metagenomi (MGX) Reports Q1 Loss, Misses Revenue Estimates
Zacks·6mo ago
News Placeholder
NewAmsterdam Pharma Company N.V. (NAMS) Reports Q1 Loss, Tops Revenue Estimates
chainwire·6mo ago
News Placeholder
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week
Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.
Stocktwits·8mo ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Metagenomi, Inc. - MGX
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Metagenomi, Inc. - MGX SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against...
PR Newswire·11mo ago
News Placeholder
MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the Schall Law Firm
MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the Schall Law Firm MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the...
PR Newswire·11mo ago

Latest MGX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.